New combination therapy offers bowel cancer patients extra treatment option

Based on scientific findings of the Netherlands Cancer Institute, a new combination treatment has been developed for patients with metastatic bowel cancer and a mutation in the BRAF gene. After a clinical trial in over 600 participants, those treated with this smart combination therapy survived longer than those who received standard treatment. The study is published today in the New England Journal of Medicine.